TENADINIR
Keep out of reach of children. Read the manual carefully before use
If need more information please consult with your doctor
COMPOSITION:
Cefdinir 300mg. Excipients q.s for 1 hard capsules
INDICATIONS AND USAGE:
Cefdinir capsules are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.
Adults and Adolescents:
Community-Acquired Pneumonia:
Caused by Haemophilus influenzae (including β-lactamase producing strains), Haemophilus parainfluenzae (including β-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including β-lactamase producing strains)
Acute Exacerbations of Chronic Bronchitis:
Caused by Haemophilus influenzae (including β-lactamase producing strains), Haemophilus parainfluenzae (including β-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including β-lactamase producing strains).
Acute Maxillary Sinusitis:
Caused by Haemophilus influenzae (including β-lactamase producing strains),
Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including β-lactamase producing strains).
NOTE: Cefdinir is effective in the eradication of S. pyogenes from the oropharynx. Cefdinir has not, however, been studied for the prevention of rheumatic fever following S. pyogenes pharyngitis/tonsillitis. Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.
Uncomplicated Skin and Skin Structure Infections:
Caused by Staphylococcus aureus (including β-lactamase producing strains) and Streptococcus pyogenes.
Pediatric Patients:
Acute Bacterial Otitis Media:
Caused by Haemophilus influenzae (including β-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including β-lactamase producing strains).
Pharyngitis/Tonsillitis:
Caused by Streptococcus pyogenes
NOTE: Cefdinir is effective in the eradication of S. pyogenes from the oropharynx. Cefdinir has not, however, been studied for the prevention of rheumatic fever following S. pyogenes pharyngitis/tonsillitis. Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.
Uncomplicated Skin and Skin Structure Infections:
Caused by Staphylococcus aureus (including β-lactamase producing strains) and Streptococcus pyogenes
CONTRAINDICATIONS:
Cefdinir is contraindicated in patients with known allergy to the cephalosporin class of antibiotics.
OTHER INFORMATION: Please refer to the Instruction sheet included in the package
MANUFACTURER: MEDIPHARCO PHARMACEUTICAL JOINT STOCK COMPANY
DISTRIBUTOR: GLOBAL PHARMACEUTICAL JOINT STOCK COMPANY
